Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PZZA | BJRI |
|---|---|---|
| Price | $19.36 | $59.32 |
| Change today | ▼ 1.12% | ▼ 3.28% |
| Market cap | $637.36M | $1.26B |
| Return, 3 months | -42.4% | -1.5% |
| Return, year to date | -48.3% | +50.6% |
| Return, 1 year | -53.5% | +90.7% |
| P/E (TTM) | 24.2 | 31.4 |
| P/B | -1.4 | 3.2 |
| P/E percentile vs own 5y | 41st | 55th |
| Dividend yield | 9.50% | – |
| Revenue growth (YoY, latest qtr) | -8.8% | +6.4% |
| Net profit growth (YoY) | -10.0% | -15.4% |
| Gross margin | 20.2% | 15.5% |
| Operating margin | 4.1% | 3.0% |
| Net margin | 1.4% | 2.9% |
| Return on equity | – | 10.4% |
| Analyst target vs. price | +52.9% | +29.8% |
| Analyst buy share | 33% | 60% |
| RSI (14) | 32 | 44 |
| 30-day volatility | 38.0% | 36.9% |
| Max drawdown, 1 year | -63.6% | -26.5% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
